Click on the button below to apply for this position.
Make an impact in a company that strives for becoming the world leader in developing antibody-based cancer products that address clear unmet needs in oncology
Y-mAbs is a fast-paced, growing company in the process of expanding its organization to support the continuous growth and the exciting clinical pipeline with activities in both early and late-stage clinical development. To support this journey Y-mAbs is now looking for an Associate Medical Director with existing experience in clinical development or clinical trials in oncology who is seeking to expand their experience and responsibilities.
As Associate Medical Director at Y-mAbs, you will join an experienced and dynamic Medical team consisting of Medical Directors in Clinical Development, Clinical Drug Safety, Pharmacovigilance and US Medical Affairs. Together, they support the clinical development, regulatory approval, scientific engagement and successful launch of medicines.
You will report to the Medical Director covering the anti-GD2 (naxitamab).
Your main tasks are:
Furthermore, you will serve as an internal resource, collaborating with all functions, providing medical input, guidance and training. In addition, you will work across the other clinical programs where required, and support the responsible Medical Directors in overseeing the planning, execution and interpretation of clinical trials.
Your qualifications include a minimum of 3 years of experience in clinical development. You have a strong teamwork attitude and are comfortable in working in cross-functional teams with medical, regulatory, saftety, data management and statistics. Your comunication and collaboration skills are excellent, and you speak and write English fluently.
A Master’s Degree in medicine (MD or equivalent) is required, combined with experience from the industry.
You are a person with a can-do attitude and a positive and proactive approch. You have the ability to work independently with multiple tasks and under ambitious timelines. Furthermore, you have great analytical skills and eye for details and good planning and problem handling abilities.
It is an exciting time to join Y-mAbs, as they have just had their first FDA approval and launch of the flagship pediatric cancer drug – Naxitamab, and further have a promising pipeline of several new cancer medicines which are both in early and late stage of development. This role will give the right person extremely valuable experience in the development, approval and launch of such medicines, and an opportunity to broaden their knowledge across multiple disease areas and indications.
Travelling: 20-25 days per year.
Domicile: You will be part of the Y-mAbs R&D Medical Department, based in the Y-mAbs Head Office in Hørsholm, Denmark.
For more details about the job or the company, please contact CEO Jørn Duhn, Unique Human Capital on M: +45 21 75 19 25 or Senior Research Consultant Jeanne Dederding, Unique Human Capital on M: +45 28 74 58 71. All applications must be in English and are treated confidentially.